Yuhong Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yuhong Zhou has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Andrew H. Sinclair
Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, VIC 3052, Australia
1 shared publication Bo Zhang
College of Mechanical and Electrical Engineering, Hebei Agricultural University, Baoding, China
1 shared publication- Chun Wang
Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
1 shared publication - Daniel G. Bracewell
Department of Biochemical Engineering University College London London UK
1 shared publication - Haitao Wang
School of Chemistry and Environmental Engineering, State Key Laboratory of Green and Efficient Development of Phosphorus Resources, Novel Catalytic Materials of Hubei Engineering Research Center, Wuhan Institute of Technology, Wuhan, China
1 shared publication - Hao Zhang
College of Mechanical and Electrical Engineering, Hebei Agricultural University, Baoding, China
1 shared publication
Latest Publications
- Open Access
- 12 October 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 10, 110064-110075
Research on Object Panoramic 3D Point Cloud Reconstruction System Based on Structure From Motion
3D reconstruction is the transformation of real objects into mathematical models. By using 3D models, we can observe the shape and measure the parameters, and help us to analyze the properties of objects. For the problems of incompleteness and inefficiency in the reconstruction of object 3D point clouds, a fast and automated system for panoramic 3D point cloud reconstruction of objects was proposed. First, we designed an automatic platform, which could acquire RGB image sequences of objects in two directions. Then we adopted the Structure From Motion (SFM) algorithm to generate point clouds. For the problem of different scales of point clouds, we obtained the scaling by calculating the length ratio of the axes of the oriented bounding box, and scaled the point clouds to a uniform scale. In addition, markers were placed around the object and used to acquire the rotation matrix of the object point cloud in two directions. Finally, we verified the point cloud models of different objects generated by the system, and found that the relative error didn’t exceed 6.67%. According to the results, the system proposed could reconstruct the panoramic 3D point cloud of the object better and provide a reference for related research.
- 12 October 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 10, 110064-110075
Open AccessResearch on Object Panoramic 3D Point Cloud Reconstruction System Based on Structure From Motion
3D reconstruction is the transformation of real objects into mathematical models. By using 3D models, we can observe the shape and measure the parameters, and help us to analyze the properties of objects. For the problems of incompleteness and inefficiency in the reconstruction of object 3D point clouds, a fast and automated system for panoramic 3D point cloud reconstruction of objects was proposed. First, we designed an automatic platform, which could acquire RGB image sequences of objects in two directions. Then we adopted the Structure From Motion (SFM) algorithm to generate point clouds. For the problem of different scales of point clouds, we obtained the scaling by calculating the length ratio of the axes of the oriented bounding box, and scaled the point clouds to a uniform scale. In addition, markers were placed around the object and used to acquire the rotation matrix of the object point cloud in two directions. Finally, we verified the point cloud models of different objects generated by the system, and found that the relative error didn’t exceed 6.67%. According to the results, the system proposed could reconstruct the panoramic 3D point cloud of the object better and provide a reference for related research.
- Open Access
- 3 February 2022
- Published by Elsevier in Procedia Computer Science
- Vol. 199, 908-915
A novel intelligent event trigger scheme on the control of delayed system with disturbance
- 3 February 2022
- Published by Elsevier in Procedia Computer Science
- Vol. 199, 908-915
Open AccessA novel intelligent event trigger scheme on the control of delayed system with disturbance
- 1 May 2013
- Published by Wolters Kluwer Health
- Vol. 34 (5) , 413-6
[Itraconazole for secondary prophylaxis of invasive fungal infection in patients undergoing chemotherapy and stem cell transplantation].
To evaluate the efficacy and safety of itraconazole for secondary prophylaxis of previous proven or probable invasive fungal infection (IFI) in patients undergoing chemotherapy or allogeneic hematopoietic stem cell transplantation (HSCT) in agranulocytosis state. A phase IV prospective, open-label, multicenter trial was conducted to evaluate itraconazole (200 mg q12h intravenously d1-2, 200 mg/d) as secondary antifungal prophylaxis in patients (18-65 years old) undergoing chemotherapy or HSCT with previous proven or probable IFI. Itraconazole was started when patients' neutrophils<1.5 × 10⁹/L, and stopped when chemotherapy patients' neutrophils >0.5 × 10⁹/L and stem cell transplant recipients' neutrophils>1.0 × 10⁹/L. The primary end-point of the study was the incidence of proven, probable or possible IFI. Seventy one patients from November 2008 to September 2010 were enrolled in the trial. The median duration of itraconazole prophylaxis was 14 (4-35) days. No patients died of drug-related toxicity within trial. Five cases occurred IFI during the trial. The cumulative incidence of invasive fungal disease was 7.0%. One patient was withdrawn from the study due to treatment-related adverse events (liver malfunction and severe phlebitis). Itraconazole appears to be safe and effective for secondary prophylaxis of systemic fungal infection after chemotherapy and allogeneic HSCT. The observed incidence of 7.0% is considerably lower than the relapse rate reported in historical controls, suggesting that itraconazole is a promising prophylactic agent in this population.
- 1 May 2013
- Published by Wolters Kluwer Health
- Vol. 34 (5) , 413-6
[Itraconazole for secondary prophylaxis of invasive fungal infection in patients undergoing chemotherapy and stem cell transplantation].
To evaluate the efficacy and safety of itraconazole for secondary prophylaxis of previous proven or probable invasive fungal infection (IFI) in patients undergoing chemotherapy or allogeneic hematopoietic stem cell transplantation (HSCT) in agranulocytosis state. A phase IV prospective, open-label, multicenter trial was conducted to evaluate itraconazole (200 mg q12h intravenously d1-2, 200 mg/d) as secondary antifungal prophylaxis in patients (18-65 years old) undergoing chemotherapy or HSCT with previous proven or probable IFI. Itraconazole was started when patients' neutrophils<1.5 × 10⁹/L, and stopped when chemotherapy patients' neutrophils >0.5 × 10⁹/L and stem cell transplant recipients' neutrophils>1.0 × 10⁹/L. The primary end-point of the study was the incidence of proven, probable or possible IFI. Seventy one patients from November 2008 to September 2010 were enrolled in the trial. The median duration of itraconazole prophylaxis was 14 (4-35) days. No patients died of drug-related toxicity within trial. Five cases occurred IFI during the trial. The cumulative incidence of invasive fungal disease was 7.0%. One patient was withdrawn from the study due to treatment-related adverse events (liver malfunction and severe phlebitis). Itraconazole appears to be safe and effective for secondary prophylaxis of systemic fungal infection after chemotherapy and allogeneic HSCT. The observed incidence of 7.0% is considerably lower than the relapse rate reported in historical controls, suggesting that itraconazole is a promising prophylactic agent in this population.
- Open Access
- 1 March 2012
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 44 (1) , 63-68
Five Cases Report of Solid Tumor Synchronously with Hematologic Malignancy
Cui Y, et al. Cancer Res Treat. 2012 Mar;44(1):63-68. http://dx.doi.org/10.4143/crt.2012.44.1.63
- 1 March 2012
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 44 (1) , 63-68
Open AccessFive Cases Report of Solid Tumor Synchronously with Hematologic Malignancy
Cui Y, et al. Cancer Res Treat. 2012 Mar;44(1):63-68. http://dx.doi.org/10.4143/crt.2012.44.1.63
- 1 January 2007
- Published by Wiley in Biotechnology Progress
- Vol. 23 (2) , 413-422
A Framework for the Prediction of Scale‐Up When Using Compressible Chromatographic Packings
Experimental data are given for the solid pressure distributions in chromatography columns of various column aspect ratios packed with four types of agarose‐based resin. The loss of column wall support at large scales can result in unexpectedly high pressures caused by the compression of the matrix via drag forces exerted by fluid flow through the bed. The need for an accurate model to predict flow conditions at increasing scale is essential for the scaling‐up of chromatographic processes and for avoiding bed compression during operation. Several studies have generated correlations that allow for the prediction of column pressure drops, but they either are mathematically complex, which impairs their practical use, or require a large number of experiments to be performed before they can be used. In this study an empirical correlation was developed based on a previously proposed model, which links the critical velocity of operation of a chromatographic system (ucrit), to the gravity‐settled bed height (L0), the column diameter (D), the feed viscosity (μ), and the compressibility of the chromatographic media used (u10%). The methodology developed in this study is straightforward to use and significantly reduces the burden of preceding laboratory‐scale experimentation. The approach can be used to predict the critical velocity of any chromatographic system and will be useful in the development of chromatographic operations and for column sizing.
- 1 January 2007
- Published by Wiley in Biotechnology Progress
- Vol. 23 (2) , 413-422
A Framework for the Prediction of Scale‐Up When Using Compressible Chromatographic Packings
Experimental data are given for the solid pressure distributions in chromatography columns of various column aspect ratios packed with four types of agarose‐based resin. The loss of column wall support at large scales can result in unexpectedly high pressures caused by the compression of the matrix via drag forces exerted by fluid flow through the bed. The need for an accurate model to predict flow conditions at increasing scale is essential for the scaling‐up of chromatographic processes and for avoiding bed compression during operation. Several studies have generated correlations that allow for the prediction of column pressure drops, but they either are mathematically complex, which impairs their practical use, or require a large number of experiments to be performed before they can be used. In this study an empirical correlation was developed based on a previously proposed model, which links the critical velocity of operation of a chromatographic system (ucrit), to the gravity‐settled bed height (L0), the column diameter (D), the feed viscosity (μ), and the compressibility of the chromatographic media used (u10%). The methodology developed in this study is straightforward to use and significantly reduces the burden of preceding laboratory‐scale experimentation. The approach can be used to predict the critical velocity of any chromatographic system and will be useful in the development of chromatographic operations and for column sizing.
- 1 December 2005
- Published by Springer Nature in Reaction Kinetics and Catalysis Letters
- Vol. 87 (1) , 33-41
Plasma treatment of Ni and Pt catalysts for partial oxidation of methane
- 1 December 2005
- Published by Springer Nature in Reaction Kinetics and Catalysis Letters
- Vol. 87 (1) , 33-41
Plasma treatment of Ni and Pt catalysts for partial oxidation of methane